+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Middle East and Africa Biochips Market 2019-2027

  • ID: 4772789
  • Report
  • Region: Africa, Middle East
  • 64 pages
  • Triton Market Research
1 of 4

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
Market Outlook

According to the author Market Research, the Middle East & Africa biochips market is anticipated to rise with a CAGR of 14.41% in estimated years 2019-2027.

The countries of Saudi Arabia, the UAE, Turkey, South Africa and rest of the Middle East and Africa together constitute the biochips market for the Middle East & African region.

There are notable investments in the biotechnology sector that aid the growth of biochips market. Private companies as well as various national governments are finding the benefits of biotechnology, and concerning this, all these organizations are highly involved in the investments in the biotechnology sector. Biochips play a vital role in molecular diagnostics, and their application in point-of-care diagnosis is expected to aid the development of personalized medicines. Focus towards personalized medicine-based analytics is enhancing growth of the biochips market. Personalized medicines have the highest safety margin and best response to ensure better patient care.

Unclear regulatory guidelines for the use of biochips in disease diagnosis and drug development is creating a challenge for the global biochips market. The regulatory bodies of different countries have a different set of rules for medical devices, thus creating an ambiguous situation for the product manufacturers as due to lack of common standards a product certified in one country may not be fit for certification in another country. Unclear regulatory guidelines for the use of biochips is creating a challenge in the growth of global biochips market.

Competitive Outlook

Some of the companies present in the biochips market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Gamida for Life Group, Cepheid, Inc., Biomerieux SA, Imgenex, Origene Technologies, Inc., Perkinelmer, Inc., Cybrdi, Inc., Agilent Technology, Inc., Biochain Institute, Inc., Fluidigm Corporation, Merck GMBH, Illumina, Inc. and Samsung Electronics, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
1. Middle East & Africa Biochips Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.3. Evolution & Transition of Biochips
2.4. Porter's Five Force Analysis
2.5. Market Attractiveness Matrix
2.6. Industry Components
2.7. Regulatory Framework
2.8. Vendor Scorecard
2.9. Key Impact Analysis
2.10. Market Opportunity Insights
2.11. Industry Player Positioning
2.12. Key Market Strategies
2.13. Market Drivers
2.13.1. Growth in Personalized Medicines
2.13.2. Rising Incidences & Treatment of Cancer
2.13.3. Constant Rise in Healthcare Spending Worldwide
2.13.4. Increasing Number of Investments in Biotechnology R&D
2.14. Market Restraints
2.14.1. Inequalities in Healthcare Access
2.14.2. Inadequate Technical Awareness Related to Biochips
2.14.3. Complexity of Biological Systems
2.15. Market Opportunities
2.15.1. Developments in Biochips Technology
2.15.2. Asia Pacific to Offer Lucrative Growth Opportunities
2.15.3. Widening Application Areas of Biochips
2.16. Market Challenges
2.16.1. Availability of Substitute Technologies
2.16.2. Unclear Regulatory Guidelines
2.16.3. Cost Constraints

3. Middle East & Africa Biochips Market Outlook - By Type
3.1. Dna Chips
3.1.1. Agricultural Biotechnology
3.1.2. Cancer Diagnostics & Treatment
3.1.3. Drug Discovery
3.1.4. Gene Expression
3.1.5. Genomics
3.1.6. Single Nucleotide Polymorphism (Snp) Genotyping
3.1.7. Other Dna Chips
3.2. Lab On a Chip
3.2.1. Clinical Diagnostics
3.2.2. Drug Discovery
3.2.3. Genomics
3.2.4. Point of Care & in Vitro Diagnosis
3.2.5. Proteomics
3.2.6. Other Lab On a Chip
3.3. Protein Chips
3.3.1. Diagnostics
3.3.2. Drug Discovery
3.3.3. Expression Profiling
3.3.4. High Throughput Screening
3.3.5. Proteomics
3.3.6. Other Protein Chips
3.4. Other Chips
3.4.1. Cell Arrays
3.4.2. Tissue Arrays

4. Middle East & Africa Biochips Market Outlook - By Substrate Material
4.1. Glass
4.2. Polymers
4.3. Silicon
4.4. Other Substrate Materials

5. Middle East & Africa Biochips Market Outlook - By End User
5.1. Biotechnology and Pharmaceutical Companies
5.2. Hospitals and Diagnostics Centers
5.3. Academic and Research Institute

6. Middle East & Africa Biochips Market - Regional Outlook
6.1. United Arab Emirates
6.2. Turkey
6.3. Saudi Arabia
6.4. South Africa
6.5. Rest of Middle East & Africa

7. Competitive Landscape
7.1. Agilent Technology Inc.
7.2. Biochain Institute Inc.
7.3. Biomerieux Sa
7.4. Bio-Rad Laboratories Inc.
7.5. Cepheid Inc.
7.6. Cybrdi Inc.
7.7. Fluidigm Corporation
7.8. Gamida For Life Group
7.9. Illumina Inc.
7.10. Imgenex
7.11. Merck Gmbh
7.12. Origene Technologies Inc.
7.13. Perkinelmer Inc.
7.14. Samsung Electronics Inc.
7.15. Thermo Fisher Scientific Inc.

8. Methodology & Scope
8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables
Table 1. Market Attractiveness Matrix For Biochips Market
Table 2. Vendor Scorecard of Biochips Market
Table 3. Regulatory Framework of Biochips Market
Table 4. Key Strategic Developments in Biochips Market
Table 5. Notable Investments Made in Biotechnology Industry in 2017
Table 6. Middle East & Africa Biochips Market, Country Outlook, 2019-2027 (In $ Million)
Table 7. Middle East & Africa Biochips Market, By Type, 2019-2027 (In $ Million)
Table 8. Middle East & Africa Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 9. Middle East & Africa Biochips Market, By End User, 2019-2027 (In $ Million)
Table 10. Middle East & Africa Biochips Market, Country Outlook, 2019-2027 (In $ Million)

List of Figures
Figure 1. Middle East & Africa Biochips Market, 2019-2027 (In $ Million)
Figure 2. Porter's Five Force Analysis of Biochips Market
Figure 3. Key Impact Analysis
Figure 4. Timeline of Biochips
Figure 5. Market Opportunity Insights, By Type, 2018
Figure 6. Market Opportunity Insights, By End User, 2018
Figure 7. Industry Components of Biochips Market
Figure 8. Key Players Positioning in 2018 (%)
Figure 9. Worldwide Healthcare Spending, By Regions, 2014-2015 (% of Gdp)
Figure 10. Comparison of Healthcare Spending Per Capita and Out of the Pocket Health Expenditure
Figure 11. Middle East & Africa Biochips Market, By Dna Chips, 2019-2027 (In $ Million)
Figure 12. Middle East & Africa Dna Chips Market, By Agricultural Biotechnology, 2019-2027 (In $ Million)
Figure 13. Middle East & Africa Dna Chips Market, By Cancer Diagnostics & Treatment, 2019-2027 (In $ Million)
Figure 14. Middle East & Africa Dna Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 15. Middle East & Africa Dna Chips Market, By Gene Expression, 2019-2027 (In $ Million)
Figure 16. Middle East & Africa Dna Chips Market, By Genomics, 2019-2027 (In $ Million)
Figure 17. Middle East & Africa Dna Chips Market, By Single Nucleotide Polymorphism (Snp) Genotyping, 2019-2027 (In $ Million)
Figure 18. Middle East & Africa Dna Chips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 19. Middle East & Africa Biochips Market, By Lab On a Chip, 2019-2027 (In $ Million)
Figure 20. Middle East & Africa Lab On a Chip Market, By Clinical Diagnostics, 2019-2027 (In $ Million)
Figure 21. Middle East & Africa Lab On a Chip Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 22. Middle East & Africa Lab On a Chip Market, By Genomics, 2019-2027 (In $ Million)
Figure 23. Middle East & Africa Lab On a Chip Market, By Point of Care & in Vitro Diagnosis, 2019-2027 (In $ Million)
Figure 24. Middle East & Africa Lab On a Chip Market, By Proteomics, 2019-2027 (In $ Million)
Figure 25. Middle East & Africa Lab On a Chip Market, By Other Lab On a Chip, 2019-2027 (In $ Million)
Figure 26. Middle East & Africa Biochips Market, By Protein Chips, 2019-2027 (In $ Million)
Figure 27. Middle East & Africa Protein Chips Market, By Diagnostics, 2019-2027 (In $ Million)
Figure 28. Middle East & Africa Protein Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 29. Middle East & Africa Protein Chips Market, By Expression Profiling, 2019-2027 (In $ Million)
Figure 30. Middle East & Africa Protein Chips Market, By High Throughput Screening, 2019-2027 (In $ Million)
Figure 31. Middle East & Africa Protein Chips Market, By Proteomics, 2019-2027 (In $ Million)
Figure 32. Middle East & Africa Protein Chips Market, By Other Protein Chips, 2019-2027 (In $ Million)
Figure 33. Middle East & Africa Biochips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 34. Middle East & Africa Other Biochips Market, By Cell Arrays, 2019-2027 (In $ Million)
Figure 35. Middle East & Africa Other Biochips Market, By Tissue Arrays, 2019-2027 (In $ Million)
Figure 36. Middle East & Africa Biochips Market, By Glass, 2019-2027 (In $ Millions)
Figure 37. Middle East & Africa Biochips Market, By Polymers, 2019-2027 (In $ Millions)
Figure 38. Middle East & Africa Biochips Market, By Silicon, 2019-2027 (In $ Millions)
Figure 39. Middle East & Africa Biochips Market, By Other Substrate Materials, 2019-2027 (In $ Millions)
Figure 40. Middle East & Africa Biochips Market, By Biotechnology and Pharmaceutical Companies, 2019-2027 (In $ Millions)
Figure 41. Middle East & Africa Biochips Market, By Hospitals and Diagnostics Centers, 2019-2027 (In $ Millions)
Figure 42. Middle East & Africa Biochips Market, By Academic and Research Institute, 2019-2027 (In $ Millions)
Figure 43. Middle East & Africa Biochips Market, Regional Outlook, 2018 & 2027 (In %)
Figure 44. United Arab Emirates Biochips Market, 2019-2027 (In $ Million)
Figure 45. Saudi Arabia Biochips Market, 2019-2027 (In $ Million)
Figure 46. Turkey Biochips Market, 2019-2027 (In $ Million)
Figure 47. South Africa Biochips Market, 2019-2027 (In $ Million)
Figure 48. Rest of Middle East & Africa Biochips Market, 2019-2027 (In $ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AGilent Technology Inc.
  • Biochain Institute Inc.
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Cybrdi Inc.
  • Fluidigm Corporation
  • Gamida For Life Group
  • Illumina Inc.
  • Imgenex
  • Merck GmbH
  • Origene Technologies Inc.
  • Perkinelmer Inc.
  • Samsung Electronics Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4772789
Adroll
adroll